ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,947, issued on May 13, was assigned to RaQualia Pharma Inc. (Nagoya, Japan) and Asahi Kasei Pharma Corp. (Tokyo).
"Tetrahydroquinoline derivatives as P2X7 receptor antagonists" was invented by Hirohide Noguchi (Nagoya, Japan), Yoshimasa Arano (Nagoya, Japan), Kazuo Ando (Nagoya, Japan), Kazuki Toyoshima (Tokyo), Toshihiko Sone (Tokyo) and Koki Matsubara (Tokyo).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to tetrahydroquinoline derivatives of the present invention or a pharmaceutically acceptable salt thereof or a prodrug thereof, processes for their preparation, pharmaceutical compositions containing them and their us...